针对质瘤的疫苗疗法:临床前沿和潜在的突破
Ying Xing1, Caixia Liu1, Yunfeng Feng2
1Key Laboratory of Clinical Research on Respiratory and Digestive Diseases, Baoding Institute of Pediatrics, Baoding Hospital of Beijing Children's Hospital, Capital Medical University, Baoding, Hebei, China.
质瘤瘤疫苗在治疗脑瘤方面表现有前途,但仍然存在挑战. 未来的策略必须通过表皮质扩散和抗原质量来增强免疫反应,以获得更好的质瘤治疗结果.
科学领域:
- 神经瘤学神经瘤学
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
背景情况:
- 质瘤是最常见的恶性脑瘤,复发率和死亡率很高.
- 有效治疗质瘤仍然是临床神经瘤学的重大挑战.
- 在过去的二十年中,在改善患者质瘤生存结果方面取得了有限的进展.
研究的目的:
- 审查当前的质瘤疫苗抗原标和类型.
- 引入最近对质瘤疫苗的临床研究.
- 提出克服质瘤疫苗治疗障碍的策略.
主要方法:
- 对质瘤疫苗的临床前和临床研究的审查.
- 分析不同类型的瘤疫苗 (,树突细胞,核酸).
- 讨论新抗原作为瘤疫苗的目标.
主要成果:
- 瘤疫苗,包括,树突细胞和核酸疫苗,是治疗质瘤的一个有希望的方法.
- 新抗原是瘤疫苗的理想目标,因为它们的特异性和抵抗免疫耐受性.
- 临床前和临床研究已经显示出滑膜瘤疫苗的有希望的结果,但挑战仍然存在.
结论:
- 未来的质瘤疫苗应用应侧重于表皮质扩散和抗原质量,以增强免疫反应和治疗效果.
- 解决当前的挑战对于疫苗治疗在质瘤治疗中的成功应用至关重要.
- 优化疫苗策略可以改善患有恶性脑瘤的患者的治疗结果.
更多相关视频
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
12:55Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
相关概念视频
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Microorganisms in Medicine and Therapeutics
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
